Peer Review History: Therapeutic CRISPR/Cas9 Genome Editing in a Humanized Mouse Model Ameliorates 𝛼1-antitrypsin Deficiency Phenotype

Editor(s):

(1) Dr. Tsygankova Victoria Anatolyivna, Institute of Bioorganic Chemistry and Petrochemistry of National Academy of Sciences of Ukraine, Ukraine.

Approved by:

(1) Dr. P. Dhasarathan, Prathyusha Engineering College, Anna University, India.

Reviewers:

(1) Mohammad Ali Khosravi, Pasteur Institute of Iran, Iran.

(2) Muntadher Abdulkareem Abdullah, Basrah college of Medicine, Basrah university, Basrah Gastroenterology and Hepatology Hospital, Iraq.

Additional Reviewers:

Additional Reviewers: (Comments received after deadline)

Peer Review History:


Peer review report_1 (Mohammad Ali Khosravi, Iran) | File 1 | NA


Peer review report_2 (Muntadher Abdulkareem Abdullah, Iraq) | File 1 | NA


Comment_Academic_Editor | File 1 | NA


Comment_Book_Editor | File 1 | NA